Skip to main content
. 2022 Jan 20;143:106955. doi: 10.1016/j.vph.2022.106955

Table 2.

Clinical and phenotypical characteristics of COVID-19 patients based on cut-offs of IL-6 and median values of LDH.


All
IL-6

LDH

Variable n = 165 0–100 mg/L (n = 110) >100 mg/L (n = 55) P <332.5 IU/L (n = 77) ≥332.5 IU/L (n = 77) P
Age 62.8 ± 11.6 61.5 ± 11.3 65.3 ± 11.9 0.051 63.1 ± 12.3 63.1 ± 10.9 0.983
Sex (F/M) 56/109 38/72 18/37 0.816 29/48 23/54 0.307
Days of admission 3.85 ± 2.70 4.27 ± 2.76 2.96 ± 2.35 0.004 3.74 ± 2.57 3.88 ± 2.88 0.758
No ICU/No mortality 130 (78.8) 101 (91.8) 29 (52.7) <0.001 61 (79.2) 59 (76.6) 0.698
ICU/mortality 35 (21.2) 9 (8.2) 26 (47.3) 16 (20.8) 18 (23.4)
Glucose at admission (mg/dL) 130.2 ± 59.1 119.9 ± 42.7 148.1 ± 77.0 0.004 121.2 ± 53.7 138.4 ± 64.1 0.087
Total cholesterol (mg/dL) 140.1 ± 32.1 142.6 ± 31.3 135.3 ± 33.2 0.246 141.5 ± 30.5 135.2 ± 32.0 0.298
LDH (IU/L) 358.1 ± 139.4 362.4 ± 150.2 350.1 ± 117.6 0.603 253.2 ± 57.3 463.1 ± 116.2 <0.001
CRP (mg/L) 132.8 ± 143.7 107.7 ± 73.9 182.1 ± 217.8 0.002 127.2 ± 193.9 150.0 ± 70.7 0.342
SBP (mmHg) 137.8 ± 21.9 137.2 ± 20.7 139.2 ± 24.2 0.578 136.4 ± 22.7 139.1 ± 21.2 0.439
DBP (mmHg) 79.1 ± 14.1 79.3 ± 14.0 78.6 ± 14.5 0.749 77.6 ± 14.4 80.6 ± 12.4 0.080
D-dimer (μg/mL) 1.71 ± 5.46 1.78 ± 6.58 1.60 ± 2.11 0.846 0.96 ± 0.98 2.53 ± 7.68 0.084
AST (IU/L) 51.1 ± 30.3 53.1 ± 34.4 47.2 ± 20.1 0.240 41.1 ± 23.3 59.7 ± 30.7 <0.001
ALT (IU/L) 40.6 ± 29.9 45.0 ± 34.5 32.0 ± 15.0 0.009 35.0 ± 25.6 43.6 ± 30.3 0.059
AST:ALT ratio 1.45 ± 0.74 1.38 ± 0.83 1.58 ± 0.53 0.057 1.31 ± 0.39 1.63 ± 0.97 0.009

Values are expressed as means ± standard deviations. P values were calculated by Student's T-tests. Bold numbers indicate P value lower than 0.05. F: female; M: male; LDH: lactate dehydrogenase; IL-6: interleukin 6; CRP: C-reactive protein; SBP: systolic blood pressure; DBP: diastolic blood pressure; AST: aspartate aminotransferase; ALT: alanine transaminase.